# New York Times Co: overview

NYT · NYSE · CIK 71691 · [Communication](/sectors/communication.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nyt.md) · [Financials](/companies/nyt/financials.md) · [Filings](/companies/nyt/filings.md) · [Insiders](/companies/nyt/insiders.md)

Latest reported revenue: [$762.5m](/filings/0000071691-26-000034.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 5, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0000071691-26-000034).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [640](/filings/0000071691-25-000126.md) | [727 d](/filings/0000071691-26-000011.md) | [636](/filings/0000071691-26-000025.md) | [686](/filings/0000071691-26-000034.md) | [701](/filings/0000071691-25-000126.md) | [802 d](/filings/0000071691-26-000011.md) | [712](/filings/0000071691-26-000025.md) | [762](/filings/0000071691-26-000034.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [12.0%](/filings/0000071691-25-000126.md) | [20.2% d](/filings/0000071691-26-000011.md) | [9.2%](/filings/0000071691-26-000025.md) | [15.5%](/filings/0000071691-26-000034.md) | [15.0%](/filings/0000071691-25-000126.md) | [20.1% d](/filings/0000071691-26-000011.md) | [12.7%](/filings/0000071691-26-000025.md) | [15.5%](/filings/0000071691-26-000034.md) |
| Net margin | % | [10.0%](/filings/0000071691-25-000126.md) | [17.0% d](/filings/0000071691-26-000011.md) | [7.8%](/filings/0000071691-26-000025.md) | [12.1%](/filings/0000071691-26-000034.md) | [11.7%](/filings/0000071691-25-000126.md) | [16.2% d](/filings/0000071691-26-000011.md) | [12.3%](/filings/0000071691-26-000025.md) | [12.3%](/filings/0000071691-26-000034.md) |
| Diluted EPS | $ per share | [0.39](/filings/0000071691-25-000126.md) | not reported | [0.30](/filings/0000071691-26-000025.md) | [0.50](/filings/0000071691-26-000034.md) | [0.50](/filings/0000071691-25-000126.md) | not reported | [0.54](/filings/0000071691-26-000025.md) | [0.57](/filings/0000071691-26-000034.md) |
| Free cash flow | $m | [118 d](/filings/0000071691-25-000126.md) | [144 d](/filings/0000071691-26-000011.md) | [89.9](/filings/0000071691-26-000025.md) | [103 d](/filings/0000071691-26-000034.md) | [200 d](/filings/0000071691-25-000126.md) | [158 d](/filings/0000071691-26-000011.md) | [81.5](/filings/0000071691-26-000025.md) | [184 d](/filings/0000071691-26-000034.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-26) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,075](/filings/0000071691-24-000030.md) | [2,308](/filings/0000071691-25-000047.md) | [2,426](/filings/0000071691-26-000011.md) | [2,586](/filings/0000071691-26-000011.md) | [2,825](/filings/0000071691-26-000011.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [12.9%](/filings/0000071691-24-000030.md) | [8.7%](/filings/0000071691-25-000047.md) | [11.4%](/filings/0000071691-26-000011.md) | [13.6%](/filings/0000071691-26-000011.md) | [15.3%](/filings/0000071691-26-000011.md) |
| Net margin | % | [10.6%](/filings/0000071691-24-000030.md) | [7.5%](/filings/0000071691-25-000047.md) | [9.6%](/filings/0000071691-26-000011.md) | [11.4%](/filings/0000071691-26-000011.md) | [12.2%](/filings/0000071691-26-000011.md) |
| Diluted EPS | $ per share | [1.31](/filings/0000071691-24-000030.md) | [1.04](/filings/0000071691-25-000047.md) | [1.40](/filings/0000071691-26-000011.md) | [1.77](/filings/0000071691-26-000011.md) | [2.09](/filings/0000071691-26-000011.md) |
| Free cash flow | $m | [234](/filings/0000071691-24-000030.md) | [114](/filings/0000071691-25-000047.md) | [338](/filings/0000071691-26-000011.md) | [381](/filings/0000071691-26-000011.md) | [551](/filings/0000071691-26-000011.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/nyt/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $1.10bn | 15,741,591 |  | Added +608,877 |
| [Berkshire Hathaway Inc](/funds/1067983.md) | 2026-06-30 | $1.10bn | 15,700,000 |  | Added +553,465 |
| [AQR CAPITAL MANAGEMENT LLC](/funds/1167557.md) | 2026-06-30 | $633.6m | 9,053,710 |  | Added +871,270 |
| [Linonia Partnership LP](/funds/1985479.md) | 2026-06-30 | $632.2m | 9,034,044 |  | Unchanged |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $513.1m | 7,332,207 |  | Reduced −347,859 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $453.8m | 6,485,390 |  | Reduced −494,794 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $352.4m | 5,036,181 |  | Reduced −81,261 |
| [Darsana Capital Partners LP](/funds/1609098.md) | 2026-06-30 | $349.9m | 5,000,000 |  | Reduced −38,727 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $340.9m | 4,864,949 |  | Added +589,112 |
| [WELLINGTON MANAGEMENT GROUP LLP](/funds/902219.md) | 2026-06-30 | $214.3m | 3,062,504 |  | Reduced −1,155,059 |

## Recent filings

[All 1,614 filings](/companies/nyt/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-09 | 11:02 ET | [8-K](/filings/0001193125-26-386067.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-386067 |
| 2026-08-05 | 14:44 ET | [10-Q](/filings/0000071691-26-000034.md) | Quarterly report, period 2026-06-30 | 0000071691-26-000034 |
| 2026-08-05 | 07:03 ET | [8-K](/filings/0000071691-26-000032.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000071691-26-000032 |
| 2026-05-06 | 15:20 ET | [10-Q](/filings/0000071691-26-000025.md) | Quarterly report, period 2026-03-31 | 0000071691-26-000025 |
| 2026-05-06 | 07:03 ET | [8-K](/filings/0000071691-26-000023.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000071691-26-000023 |
| 2026-04-23 | 17:05 ET | [8-K](/filings/0000071691-26-000019.md) | 5.07 Shareholder vote results | 0000071691-26-000019 |
| 2026-03-13 | 08:42 ET | [DEF 14A](/filings/0000071691-26-000016.md) | Proxy statement, period 2026-04-22 | 0000071691-26-000016 |
| 2026-02-27 | 11:37 ET | [10-K](/filings/0000071691-26-000011.md) | Annual report, period 2025-12-31 | 0000071691-26-000011 |
| 2026-02-04 | 07:01 ET | [8-K](/filings/0000071691-26-000008.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000071691-26-000008 |
| 2026-01-21 | 16:18 ET | [8-K](/filings/0000071691-26-000003.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000071691-26-000003 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0000071691-26-000011.md), filed Feb 27, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/e38d54fe-ade6-49e8-b559-b6ee95ec6963)

## About the filer

- CIK: 71691
- Tickers: NYT
- Exchange: NYSE
- SIC code: 2711 Newspapers: Publishing or  Publishing & Printing
- State of incorporation: NY
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 26, 2026, 17:08 ET. No prices; not investment advice.